Antagonism of the Muscarinic Acetylcholine Type 1 Receptor Enhances Mitochondrial Membrane Potential and Expression of Respiratory Chain Components via AMPK in Human Neuroblastoma SH-SY5Y Cells and Primary Neurons
Open Access
- 25 August 2022
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 59 (11) , 6754-6770
Abstract
Impairments in mitochondrial physiology play a role in the progression of multiple neurodegenerative conditions, including peripheral neuropathy in diabetes. Blockade of muscarinic acetylcholine type 1 receptor (M1R) with specific/selective antagonists prevented mitochondrial dysfunction and reversed nerve degeneration in in vitro and in vivo models of peripheral neuropathy. Specifically, in type 1 and type 2 models of diabetes, inhibition of M1R using pirenzepine or muscarinic toxin 7 (MT7) induced AMP-activated protein kinase (AMPK) activity in dorsal root ganglia (DRG) and prevented sensory abnormalities and distal nerve fiber loss. The human neuroblastoma SH-SY5Y cell line has been extensively used as an in vitro model system to study mechanisms of neurodegeneration in DRG neurons and other neuronal sub-types. Here, we tested the hypothesis that pirenzepine or MT7 enhance AMPK activity and via this pathway augment mitochondrial function in SH-SY5Y cells. M1R expression was confirmed by utilizing a fluorescent dye, ATTO590-labeled MT7, that exhibits great specificity for this receptor. M1R antagonist treatment in SH-SY5Y culture increased AMPK phosphorylation and mitochondrial protein expression (OXPHOS). Mitochondrial membrane potential (MMP) was augmented in pirenzepine and MT7 treated cultured SH-SY5Y cells and DRG neurons. Compound C or AMPK-specific siRNA suppressed pirenzepine or MT7-induced elevation of OXPHOS expression and MMP. Moreover, muscarinic antagonists induced hyperpolarization by activating the M-current and, thus, suppressed neuronal excitability. These results reveal that negative regulation of this M1R-dependent pathway could represent a potential therapeutic target to elevate AMPK activity, enhance mitochondrial function, suppress neuropathic pain, and enhance nerve repair in peripheral neuropathy.Keywords
All Related Versions
Funding Information
- Institute of Neurosciences, Mental Health and Addiction (PJT-162172)
- Mitacs
This publication has 102 references indexed in Scilit:
- Muscarinic Receptors as Model Targets and Antitargets for Structure-Based Ligand DiscoveryMolecular Pharmacology, 2013
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetesBrain, 2012
- Modulating molecular chaperones improves sensory fiber recovery and mitochondrial function in diabetic peripheral neuropathyExperimental Neurology, 2012
- Nutrient excess and altered mitochondrial proteome and function contribute to neurodegeneration in diabetesMitochondrion, 2011
- Mitophagy Selectively Degrades Individual Damaged Mitochondria After PhotoirradiationAntioxidants & Redox Signaling, 2011
- NeuralKCNQ(Kv7) channelsBritish Journal of Pharmacology, 2009
- Immortalization and characterization of a nociceptive dorsal root ganglion sensory neuronal lineJournal of the Peripheral Nervous System, 2007
- Resveratrol stimulates AMP kinase activity in neuronsProceedings of the National Academy of Sciences, 2007
- Rapid Chemically Induced Changes of PtdIns(4,5)P 2 Gate KCNQ Ion ChannelsScience, 2006